Reply:  by Johnson, Robert G. et al.
Atrial fibrillation after minimally invasive coronary
artery bypass
To the Editor:
The article by Cohn, Sirois, and Johnson1 in the February
1999 issue of the Journal regarding minimally invasive coro-
nary artery bypass (MIDCAB) versus conventional bypass is
notable for its failure to specify the number of vessels with
critical stenoses in each group vis-à-vis the difference in the
number of anastomoses (1.1 vs 3.6). Therefore the issue of
complete versus incomplete revascularization is open in
regard to its potential contribution to equalizing the incidence
of postoperative atrial fibrillation of both groups.
Noted also is a 9% incidence of “revision” for the group
undergoing MIDCAB. The text does not elaborate on the
nature of the “revision,” its timing after the first surgical pro-
cedure, and the incidence of atrial fibrillation in that subset of
patients. Without this information, one may not draw any
inferences on the incidence and cause of postoperative atrial
fibrillation in the MIDCAB group.
Michael Nathanson, MD, PhD
Division of Cardiothoracic Surgery
Santa Clara Valley Medical Center
751 S Bascom Ave
San Jose, CA 95128
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Our study was intended to examine whether the incidence
of postoperative atrial fibrillation was higher after conven-
tional (CCAB) compared with minimally invasive (MIDCAB)
coronary bypass operations. Nathanson questions whether our
MIDCAB patients might be less well revascularized than their
CCAB counterparts and experiencing an increased incidence
of atrial fibrillation as a consequence of that less complete
revascularization. As Nathanson notes, our MIDCAB patients
received fewer grafts on average than our CCAB patients, but
this fact merely reflects the difference in the selection of
patients for the two procedures. In our Methods section we
cited the fact that 14 of our 55 MIDCAB patients had “more
than single left anterior descending coronary disease.”1 These
MIDCAB patients were treated as part of a culprit strategy
and had identifiable, clinically significant lesions in graftable
vessels. In response to this interesting query, we looked back
at the coronary lesion data on all 110 patients. Seventeen of
the MIDCAB patients had 3-vessel involvement, and their
incidence of atrial fibrillation was 17.6%. This is the same as
the 15.8% incidence of atrial fibrillation among the 39
patients with 3-vessel disease having CCAB. These data do
not suggest a relationship between completeness of revascu-
larization and postoperative atrial fibrillation.
Nathanson’s second concern regards the nature and timing
of “revision” in 5 of our 55 MIDCAB patients. With respect
to the timing of these revisions, we2,3 have previously cited
our practice of obtaining angiograms in all patients with nor-
mal renal function within 24 hours of their MIDCAB opera-
tion. Our rate of revision is consistent with the abnormalities
reported in other consecutive series of early post-MIDCAB
angiograms.4 All revisions were accomplished in that same
24-hour interval. The nature of the revisions is actually pre-
sented in our Results section (2 revisions for kinking and 3
anastomotic revisions), as is the incidence of atrial fibrillation
in among these patients (1 of the 5). If any conclusion can be
drawn from such a small number of patients, revision does not
seem to be a factor in the incidence of postprocedure atrial
fibrillation.
Our data challenge prevalent notions about the cause of atri-
al fibrillation after coronary artery bypass grafting. Although
the results surprised us as much as they may have frustrated
Nathanson, we cannot but conclude that, if one corrects for
age, the incidence of postoperative atrial fibrillation is not
lower in MIDCAB patients than in CCAB patients. We look
forward to increasing our experience with these procedures,
as well as to data from other investigators who may select a
population for MIDCAB procedures that is somewhat differ-
ent from our own.
Robert G. Johnson, MD
William E. Cohn, MD
Cheryl A. Sirois, RN
Division of Cardiothoracic Surgery
Beth Israel Deaconess Medical Center
330 Brookline Ave
Boston, MA 02215
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